Navigation Links
GeneThera - CHANGING DIRECTIONS - an Update to Shareholders
Date:11/3/2008

WHEAT RIDGE, Colo., Nov. 3 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), As a service and responsibility to our shareholders, GeneThera is publicly outlining our strategy for the future of the company. GeneThera is making a pivotal shift from a Research and Development organization into a product marketing and revenue generating entity.

The company strategy that we maintained from inception to our recent reverse split (July, 2008) had been one of research only. We focused all our energies, talent, and resources to the incubation and growth of new ideas in the realm of genetically engineered disease detection and vaccination. We feel that with recent announcements the company is positioned to move from a developmental stage to a product oriented stage

RECENT DEVELOPMENTS

Our recent developments include the progress we are making in regards to our Johne's Disease validation trials scheduled to begin in collaboration with the Universidad National Autonoma de Mexico, a prominent state university in Mexico City. Our joint venture with Nutricion Avanzada, (the joint venture created a new company Applied Genetics. Applied Genetics is the marketing arm of GeneThera for the Mexican marketing of our Johne's Disease testing service and subsequent Vaccine, (which is currently under development) has been in contact with several major ranchers throughout Mexico, and the overwhelming response from the ranchers has been an outcry for help in detecting and eliminating Johne's Disease which is running rampant in their herds. Government approval and recommendation is expected to occur quickly once the validation trials are complete. The validation trials should be complete within 3-4 months from start. We will be conducting paid testing on a limited basis during the validation trials.

The recent signing of our agreement with STC.UNM (the technology development arm of The University of New Mexico) for the genetic vaccine they have dev
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Changing the way doctors treat high blood pressure
2. Use of intraoperative MRI adds time but care-changing information to neurosurgery, study shows
3. AAPPO and HCAA Form Partnership to Enhance Services to Meet the Changing Business Needs of PPOs and TPAs
4. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
5. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
6. Fish devastated by sex-changing chemicals in municipal wastewater
7. Lupus Advocates Seek Increased Federal Response to Life-Changing, Life-Threatening Disease Affecting 1.5 Million Americans
8. Freeland, MI Woman Wins $50,000 for Losing Weight, Adding Muscle and Changing Her Life
9. The Changing Face of Medicine: National Medical Fellowships Annual Awards Gala Honors Three Fellows
10. Changing school environment curbs weight gain in children
11. Pennsylvania Health Secretary Focuses on Changing the Climate of Health Care During National Public Health Week
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Study finds air traffic control tracking method reduces errors in trauma management 48657 1Study finds air traffic control tracking method reduces errors in trauma management 48657 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 1Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 2Survey Results Show Long Term Care Providers Wary about Healthcare Reform 48652 3New American College of Surgeons risk calculator determines colorectal surgery risk 48647 1New American College of Surgeons risk calculator determines colorectal surgery risk 48647 2New American College of Surgeons risk calculator determines colorectal surgery risk 48647 3